Cardiovascular Diseases (CVD) are often caused by a combination of a genetic predisposition and an unhealthy lifestyle. CVD StripAssays® and RealFast™ Assays identify various combinations of genetic CVD risk factors.
Cardiovascular Diseases (CVD)
- The two major manifestations of CVD are atherosclerosis and venous thrombosis.
- The risk for atherosclerosis is increased by the combination of an unhealthy lifestyle and variants of genes involved in endothelial dysfunction, hyperlipidemia, hypertension, and inflammation.
- Correspondingly, the interplay of adverse influences (female hormone intake, lack of physical activity, surgery, cancer) and certain genetic variants enhance the susceptibility to develop thrombosis.
- Testing for disease-associated genetic variants in conjunction with an adaptation of life style can greatly contribute to decrease an individual's CVD risk.
pdf Productnote 01: CVD Marker
Product | REF | Unit Size | IFU | Brochure |
---|---|---|---|---|
FV-PTH-MTHFR StripAssay® | 4-260 | 20 tests | ||
Apo E StripAssay® | 4-280 | 20 tests | ||
FV-PTH StripAssay® | 4-290 | 20 tests | ||
CVD StripAssay® T | 4-360 | 20 tests | ||
CVD StripAssay® A | 4-370 | 20 tests | ||
FV Leiden RealFast™ Assay | 7-1107-113 | 100 rxn 32 rxn | ||
FV-PTH mpx RealFast™ Assay | 7-1157-118 | 100 rxn 32 rxn | ||
PTH 20210G>A RealFast™ Assay | 7-1207-123 | 100 rxn 32 rxn | ||
MTHFR 677C>T RealFast™ Assay | 7-1607-163 | 100 rxn 32 rxn | ||
MTHFR mpx RealFast™ Assay | 7-1657-168 | 100 rxn 32 rxn | ||
MTHFR 1298A>C RealFast™ Assay | 7-1707-173 | 100 rxn 32 rxn | ||
PAI-1 4G/5G RealFast™ Assay | 7-1807-183 | 100 rxn 32 rxn | ||
FGB -455G>A RealFast™ Assay | 7-2307-233 | 100 rxn 32 rxn | ||
FXII 46C>T RealFast™ Assay | 7-2407-243 | 100 rxn 32 rxn | ||
FXIII V34L RealFast™ Assay | 7-2507-253 | 100 rxn 32 rxn |